Skip to the page

Data / Form D filings / PharmAbbie, Inc.

PharmAbbie, Inc.: Form D filing

PharmAbbie, Inc., a pharmaceuticals company in Groton, CT, filed a Form D with the SEC in 2021. The latest, on August 12, 2021, reports an offering of $15 million with nothing sold yet.

Find out what PharmAbbie, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
37 SKYLINE DRIVE, Groton, CT, 06340
Phone
(860) 910-5486
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1877360

The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 12, 2021New notice$15,000,000$0$15,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Serge R. MartinodExecutive Officer, Director
George R. MurphyExecutive Officer, Director
Disma R. MazzolaDirector

Other pharmaceuticals companies in Connecticut that filed recently

Every Form D from the week of Aug 9, 2021 · All recent filings in Connecticut · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what PharmAbbie, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.